351 related articles for article (PubMed ID: 18628403)
61. Further exploration of M₁ allosteric agonists: subtle structural changes abolish M₁ allosteric agonism and result in pan-mAChR orthosteric antagonism.
Sheffler DJ; Sevel C; Le U; Lovell KM; Tarr JC; Carrington SJ; Cho HP; Digby GJ; Niswender CM; Conn PJ; Hopkins CR; Wood MR; Lindsley CW
Bioorg Med Chem Lett; 2013 Jan; 23(1):223-7. PubMed ID: 23200253
[TBL] [Abstract][Full Text] [Related]
62. Cholinergic M
Ruan H; Sun J; Liu X; Liu L; Cui R; Li X
Behav Brain Res; 2019 Mar; 360():128-133. PubMed ID: 30529589
[TBL] [Abstract][Full Text] [Related]
63. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
64. Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.
Thomas RL; Langmead CJ; Wood MD; Challiss RA
J Pharmacol Exp Ther; 2009 Dec; 331(3):1086-95. PubMed ID: 19767446
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
[TBL] [Abstract][Full Text] [Related]
66. Design, synthesis and evaluation of novel 2-phenyl-3-(1H-pyrazol-4-yl)pyridine positive allosteric modulators for the M
Jörg M; van der Westhuizen ET; Lu Y; Christopher Choy KH; Shackleford DM; Khajehali E; Tobin AB; Thal DM; Capuano B; Christopoulos A; Valant C; Scammells PJ
Eur J Med Chem; 2023 Oct; 258():115588. PubMed ID: 37423123
[TBL] [Abstract][Full Text] [Related]
67. Potentiation of Muscarinic M
Okimoto R; Ino K; Ishizu K; Takamatsu H; Sakamoto K; Yuyama H; Fuji H; Someya A; Ohtake A; Ishigami T; Masuda N; Takeda M; Kajioka S; Yoshimura N
J Pharmacol Exp Ther; 2021 Oct; 379(1):64-73. PubMed ID: 34244231
[TBL] [Abstract][Full Text] [Related]
68. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
[TBL] [Abstract][Full Text] [Related]
69. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
[TBL] [Abstract][Full Text] [Related]
70. Positive allosteric modulation of M
Yohn SE; Conn PJ
Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
[TBL] [Abstract][Full Text] [Related]
71. Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
Jendryka M; Palchaudhuri M; Ursu D; van der Veen B; Liss B; Kätzel D; Nissen W; Pekcec A
Sci Rep; 2019 Mar; 9(1):4522. PubMed ID: 30872749
[TBL] [Abstract][Full Text] [Related]
72. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.
Haga K; Kruse AC; Asada H; Yurugi-Kobayashi T; Shiroishi M; Zhang C; Weis WI; Okada T; Kobilka BK; Haga T; Kobayashi T
Nature; 2012 Jan; 482(7386):547-51. PubMed ID: 22278061
[TBL] [Abstract][Full Text] [Related]
73. Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
Jakubík J; Bacáková L; Lisá V; el-Fakahany EE; Tucek S
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8705-9. PubMed ID: 8710935
[TBL] [Abstract][Full Text] [Related]
74. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
[TBL] [Abstract][Full Text] [Related]
75. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
[TBL] [Abstract][Full Text] [Related]
76. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
[TBL] [Abstract][Full Text] [Related]
77. Regulation of signal transduction at M2 muscarinic receptor.
Krejcí A; Michal P; Jakubík J; Rícný J; Dolezal V
Physiol Res; 2004; 53 Suppl 1():S131-40. PubMed ID: 15119944
[TBL] [Abstract][Full Text] [Related]
78. Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors.
Christopoulos A; Wilson K
Brain Res; 2001 Oct; 915(1):70-8. PubMed ID: 11578621
[TBL] [Abstract][Full Text] [Related]
79. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
[TBL] [Abstract][Full Text] [Related]
80. Prediction of functionally selective allosteric interactions at an M3 muscarinic acetylcholine receptor mutant using Saccharomyces cerevisiae.
Stewart GD; Sexton PM; Christopoulos A
Mol Pharmacol; 2010 Aug; 78(2):205-14. PubMed ID: 20466821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
